Literature DB >> 22129255

Systemic lupus erythematosus.

George C Tsokos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22129255     DOI： 10.1056/NEJMra1100359

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  923 in total

1.  Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.

Authors:  Yudong Liu; Yaíma L Lightfoot; Nickie Seto; Carmelo Carmona-Rivera; Erica Moore; Rishi Goel; Liam O'Neil; Pragnesh Mistry; Victoria Hoffmann; Santanu Mondal; Padmavathy Nandha Premnath; Katherine Gribbons; Stefania Dell'Orso; Kan Jiang; Paul R Thompson; Hong-Wei Sun; Scott A Coonrod; Mariana J Kaplan
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

3.  Renal-infiltrating CD11c+ cells are pathogenic in murine lupus nephritis through promoting CD4+ T cell responses.

Authors:  X Liao; J Ren; A Reihl; T Pirapakaran; B Sreekumar; T E Cecere; C M Reilly; X M Luo
Journal:  Clin Exp Immunol       Date:  2017-08-18       Impact factor: 4.330

4.  Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus.

Authors:  Jian Zhao; Hui Wu; Carl D Langefeld; Kenneth M Kaufman; Jennifer A Kelly; Sang-Cheol Bae; Graciela S Alarcón; Juan-Manuel Anaya; Lindsey A Criswell; Barry I Freedman; Diane L Kamen; Gary S Gilkeson; Chaim O Jacob; Judith A James; Joan T Merrill; Patrick M Gaffney; Kathy Moser Sivils; Timothy B Niewold; Michelle A Petri; Seung Taek Song; Hye-Jin Jeong; Rosalind Ramsey-Goldman; John D Reveille; R Hal Scofield; Anne M Stevens; Susan A Boackle; Luis M Vilá; Deh-Ming Chang; Yeong Wook Song; Timothy J Vyse; John B Harley; Elizabeth E Brown; Jeffrey C Edberg; Robert P Kimberly; Bevra H Hahn; Jennifer M Grossman; Betty P Tsao; Antonio La Cava
Journal:  Clin Immunol       Date:  2015-09-16       Impact factor: 3.969

5.  The Synergy of Endotoxin and (1→3)-β-D-Glucan, from Gut Translocation, Worsens Sepsis Severity in a Lupus Model of Fc Gamma Receptor IIb-Deficient Mice.

Authors:  Jiraphorn Issara-Amphorn; Saowapha Surawut; Navaporn Worasilchai; Arthid Thim-Uam; Malcolm Finkelman; Ariya Chindamporn; Tanapat Palaga; Nattiya Hirankarn; Prapaporn Pisitkun; Asada Leelahavanichkul
Journal:  J Innate Immun       Date:  2018-01-31       Impact factor: 7.349

6.  Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.

Authors:  R R Winkelmann; Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-01

7.  Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.

Authors:  Zhi-Wei Lai; Ryan Kelly; Thomas Winans; Ivan Marchena; Ashwini Shadakshari; Julie Yu; Maha Dawood; Ricardo Garcia; Hajra Tily; Lisa Francis; Stephen V Faraone; Paul E Phillips; Andras Perl
Journal:  Lancet       Date:  2018-03-15       Impact factor: 79.321

8.  A T cell gene expression panel for the diagnosis and monitoring of disease activity in patients with systemic lupus erythematosus.

Authors:  Alexandros P Grammatikos; Vasileios C Kyttaris; Katalin Kis-Toth; Lisa M Fitzgerald; Amy Devlin; Michele D Finnell; George C Tsokos
Journal:  Clin Immunol       Date:  2013-12-16       Impact factor: 3.969

9.  Unbiased modifier screen reveals that signal strength determines the regulatory role murine TLR9 plays in autoantibody production.

Authors:  Robyn E Mills; Viola C Lam; Allison Tan; Nicole Cresalia; Nir Oksenberg; Julie Zikherman; Mark Anderson; Arthur Weiss; Michelle L Hermiston
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

10.  Autoantibodies against C-Reactive Protein Influence Complement Activation and Clinical Course in Lupus Nephritis.

Authors:  Qiu-Yu Li; Hai-Yun Li; Ge Fu; Feng Yu; Yi Wu; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2017-05-31       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.